Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Elicio Therapeutics, Inc. (ANGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
8-K
| Quarterly results |
| 08/11/2023 |
8-K
| Quarterly results |
| 06/02/2023 |
8-K
| Completion of Acquisition or Disposition of Assets, Material Modifications to Rights of Security Holders, Changes in Registra...|
Docs:
|
"Certificate of Merger",
"Certificate of Amendment, to the Amended and Restated Certificate of Incorporation of Angion Biomedica Corp. to implement the Reverse Stock Split",
"Certificate of Amendment, to the Amended and Restated Certificate of Incorporation of Angion Biomedica Corp. to implement Officer Exculpation",
"Certificate of Amendment, to the Amended and Restated Certificate of Incorporation of Angion Biomedica Corp. to implement the name change",
"Suite 501 Boston, MA 02210",
"Form of Indemnification Agreement between the Company and each of its directions and officers",
"Information Rights Letter, by and between Clal Biotechnology Industries Ltd. and Elicio Therapeutics, Inc",
"Letter from Moss Adams LLP",
"NEWTON, Massachusetts, June 1, 2023 ––",
"Elicio Therapeutics Announces Completion of Merger with Angion Biomedica" |
|
| 05/30/2023 |
8-K
| Other Events Interactive Data |
| 05/23/2023 |
8-K
| Other Events Interactive Data |
| 05/01/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/27/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...|
Docs:
|
"Agreement and Plan of Merger and Reorganization, by and among Angion Biomedica Corp., Arkham Merger Sub, Inc. and Elicio Therapeutics, Inc",
"Note Purchase Agreement, by and between Elicio Therapeutics, Inc. and Angion Biomedica Corp., and Form of Promissory Note",
"Form of Angion Biomedica Corp. Stockholder Support Agreement",
"Form of Elicio Therapeutics, Inc. Stockholder Support Agreement",
"Form of Lock-Up Agreement",
"No Offer or Solicitation This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No public offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended." |
|
| 12/21/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 08/15/2022 |
8-K
| Quarterly results |
| 07/25/2022 |
8-K
| Quarterly results |
| 06/29/2022 |
8-K
| Quarterly results |
| 06/13/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 03/30/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/04/2022 |
8-K
| Quarterly results |
| 01/04/2022 |
8-K
| Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities Interactive ... |
| 11/12/2021 |
8-K
| Quarterly results |
| 10/26/2021 |
8-K
| Results of Operations and Financial Condition Interactive Data |
| 08/30/2021 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
| 08/12/2021 |
8-K
| Quarterly results |
| 06/29/2021 |
8-K
| Quarterly results |
| 05/17/2021 |
8-K
| Quarterly results |
| 03/30/2021 |
8-K
| Quarterly results |
| 03/10/2021 |
8-K
| Quarterly results |
| 02/09/2021 |
8-K
| Quarterly results |
|
|